I
mpaired fasting glucose (IFG) and impaired glucose tolerance (IGT) represent intermediate states between normal fasting glucose (NFG) or normal glucose tolerance (NGT), respectively, and diabetes (1). The regulation of fasting and glucose concentrations after an oral glucose load is dependent on different physiological mechanisms (2), and current evidence suggests that IFG and IGT have different pathophysiologies (3,4). Measurement of fasting plasma glucose (FPG) is the most frequently used screening test for diabetes. However, the oral glucose tolerance test (OGTT) might be a preferable test because FPG underestimates the severity of glucose intolerance (5, 6) and because IFG and IGT define two distinct populations with only partial overlap (5, 7, 8) . The present study was undertaken to compare insulin sensitivity and insulin secretion profiles associated with different stages of hyperglycemia as assessed by FPG only or by FPG and 2-h plasma glucose during an OGTT.
RESEARCH DESIGN AND
METHODS -We analyzed data from 900 subjects without previously known diabetes who underwent an OGTT for diagnostic purposes at Fleury Institute, São Paulo, Brazil. A double-glycemic status was determined for each subject. A first set was based on FPG only as follows: NFG (FPG Ͻ5.6 mmol/l), IFG (5.6 mmol/l Յ FPG Ͻ7.0 mmol/l), and diabetes (FPG Ն7.0 mmol/l). Subjects with IFG were further stratified into two groups according to the severity of FPG: IFG new criteria (IFG nc ) (5.6 mmol/l Յ FPG Ͻ6.1 mmol/l) and IFG old criteria (IFG oc ) (6.1 mmol/l Յ FPG Ͻ7.0 mmol/l) (1). A second set of glycemic status values was based on both FPG and 2-h plasma glucose as follows: NFG/NGT (FPG Ͻ5.6 mmol/l and 2-h plasma glucose Ͻ7.8 mmol/l), isolated IFG (5.6 mmol/l Յ FPG Ͻ7.0 mmol/l and 2-h plasma glucose Ͻ7.8 mmol/l), isolated IGT (FPG Ͻ5.6 mmol/l and 7.8 Յ 2-h plasma glucose Ͻ11.1 mmol/l), combined IFG/IGT (5.6 mmol/l Յ FPG Ͻ7.0 mmol/l and 7.8 Յ 2-h plasma glucose Ͻ11.1 mmol/l), and diabetes (FPG Ն7.0 mmol/l or 2-h plasma glucose Ն11.1 mmol/l). ␤-Cell function was estimated as the ratio of ⌬insulin 30 -0 min to glucose 30 min (9) . Insulin sensitivity was estimated by Matsuda's composite index (10) and by homeostasis model assessment of insulin sensitivity (HOMA%S) (11) . Differences between groups were assessed by ANOVA with log-transformed data. Comparisons between pairs were made using the Tukey-Kramer honestly significant difference (HSD) test. Insulin secretion was compared between groups with adjustment for insulin sensitivity levels (HOMA%S) during regression analyses.
RESULTS -Subjects with IFG nc , IFG oc , or diabetes as defined by FPG had lower insulin sensitivity than subjects with NFG, but there were no differences in insulin sensitivity among the hyperglycemic groups (Table 1) . Insulin secretion decreased with the severity of hyperglycemia and was significantly different in all intergroup comparisons.
When OGTT-based glycemic status was considered, subjects with isolated IFG or with isolated IGT had decreased insulin sensitivity that was intermediate between that of subjects with NFG/NGT and that of subjects with both IFG/IGT and diabetes (Table 1 ). The ⌬insulin 30 -0 min -toglucose 30 min ratio was decreased in all groups with hyperglycemia compared with values in subjects with NFG/NGT. Similar values were observed in subjects with isolated IFG or with isolated IGT that were intermediate between those in subjects with NFG/NGT and those in subjects with combined IFG/IGT or with diabetes.
We have looked at the correlation between hyperglycemic status determined by FPG only and by FPG and 2-h plasma glucose. FPG-based stratification underestimated the severity of hyperglycemia and glucose intolerance, as 19% of subjects with NFG had IGT and 3% had diabetes when we considered the OGTTbased stratification. Moreover, 44% of subjects with IFG in the FPG-based stratification also had IGT and 24% had diabetes according to the OGTT-based criteria.
CONCLUSIONS -We have observed that the increase in the severity of hyper- glycemia assessed by FPG only or by the OGTT is associated with different profiles of insulin sensitivity and insulin secretion. When glycemic status was assessed by FPG only, differences in IFG and diabetes were best explained by the degree of ␤-cell defects, as both dysglycemic states were associated with similar degrees of insulin resistance. The new FPG cutoff for defining IFG (Յ5.6 mmol/l) identifies subjects with decreased insulin sensitivity and decreased ␤-cell function compared with subjects with NFG/NGT but with a lesser degree of insulin secretion deficit than subjects defined by the older FPG cutoff (Յ6.1 mmol/l). When we take into account both FPG and 2-h plasma glucose, the severity of hyperglycemia and glucose intolerance was associated with progressive decreases in insulin sensitivity and in insulin secretion. These differences in insulin sensitivity and insulin secretion profiles when hyperglycemia was diagnosed by FPG only or by the OGTT are due to the underestimation by FPG of the severity of glucose intolerance. Our results are in agreement with other studies suggesting that FPG remains a poor discriminator of IGT and of diabetes (5,6). Our analysis illustrates the effects of using FPG as the single test of glycemic status. Even with the new cutoff for IFG (FPG Ն5.6 mmol/l), ϳ25% of subjects with IGT or diabetes would be misclassified as normal.
In summary, our data demonstrate that different patterns of insulin sensitivity and insulin secretion are associated with the increase in the severity of hyperglycemia assessed by FPG only or by FPG and the 2-h plasma glucose during an OGTT. 
